Top

Published in:

01-02-2014 | Review Article

Role of Endomyocardial Biopsy for Children Presenting With Acute Systolic Heart Failure

Author: Bibhuti B. Das

Published in: Pediatric Cardiology | Issue 2/2014

Abstract

Myocarditis, an inflammatory disease of the heart, frequently results from viral infections, postviral immune-mediated responses, or both. It is a common cause of acute-onset systolic heart failure in children. Endomyocardial biopsy (EMB) remains the gold standard for the diagnosis of myocarditis. However, EMB is not performed for most myocarditis cases involving children in the United States. Clinical scenarios in which EMB results added unique prognostic data and guidance to therapy have been defined recently. This review outlines the role of EMB in the diagnosis and management of myocarditis for children presenting with acute-onset systolic heart failure.

Angelini A, Calzolaari V, Boffa GM, Maddalena F, Chioin R, Thiene G (2000) Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis. Heart 84:245–250PubMedCentralCrossRefPubMed

Aretz HT, Billingham ME, Edwards WD et al (1987) Myocarditis: a histopathological definition and classification. Am J Cardiovasc Pathol 1:3–14PubMed

Baughman KL (2006) Diagnosis of myocarditis: death of Dallas criteria. Circulation 113:593–595CrossRefPubMed

Blauwet LA, Cooper LT (2010) Myocarditis. Prog Cardiovasc Dis 52:274–288CrossRefPubMed

Breinholt JP, Moulik M, Dreyer WJ et al (2010) Viral epidemiologic shift in inflammatory heart disease: the interesting involvement of parvovirus B19 in the myocardium of pediatric cardiac transplant patients. J Heart Lung Transplant 29:739–746PubMedCentralCrossRefPubMed

Chow LH, Radio SJ, Sears TD, McManus BM (1989) Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol 14:915–920CrossRefPubMed

Cooper LT, Baughman KL, Feldman AM et al (2007) AHA/ACCF/ESC scientific statement: the role of endomyocardial biopsy in the management of cardiovascular disease. Circulation 50:1914–1931

Crossland DS, Edmonds K, Rassl D et al (2008) Histology of explanted hearts in children transplanted for dilated cardiomyopathy. Pediatr Transplant 12:85–90CrossRefPubMed

Daly KP, Marshall AC, Vincent JA et al (2012) Endomyocardial biopsy and selective coronary angiography are low-risk procedures in pediatric heart transplant recipients: results of a multicenter experience. J Heart Lung Transplant 31:398–409PubMedCentralCrossRefPubMed

10.

D’Ambrosio A, Patti G, Mazoli A et al (2001) The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 85:499–504PubMedCentralCrossRefPubMed

11.

Daubency PE, Nugent AW, Chondors P, National Australian Childhood Cardiomyopathy Study et al (2006) Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation 114:2671–2678CrossRef

12.

Dennert R, Crijns HJ, Heyman S (2008) Acute viral myocarditis. Eur Heart J 29:2073–2082PubMedCentralCrossRefPubMed

13.

Felker GM, Boehmer JP, Hruban RH et al (2000) Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 36:227–232CrossRefPubMed

14.

Foerster SR, Canter CE, Cinar A et al (2010) Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic cardiomyopathy in childhood: an outcome study from the pediatric cardiomyopathy registry. Circ Heart Fail 3:689–697CrossRefPubMed

15.

Friedrich MG, Sechtem U, Shulz-Menger J et al (2009) Cardiovascular magnetic resonance in myocarditis: a JACC white paper. International Sensus Group on Cardiovascular Magnetic Resonance in Myocarditis. J Am Coll Cardiol 53:1475–1487PubMedCentralCrossRefPubMed

16.

Freimuth P, Philipson L, Carson SD (2008) The Coxsackie virus and adenovirus receptor. Curr Top Microbiol Immunol 323:67–87PubMed

17.

Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A (2003) Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunological profile of responders versus nonresponders. Circulation 107:857–863CrossRefPubMed

18.

Frustaci A, Russo MA, Chimenti C (2009) Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathies: the TIMC study. Eur Heart J 30:1995–2002CrossRefPubMed

19.

Gagliardi MG, Bevilacqua M, Di Renzi P, Picardo S, Passariello R, Marcelletti C (1991) Usefulness of magnetic resonance imaging for diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy. Am J Cardiol 68:1089–1091CrossRefPubMed

20.

Hauck AJ, Kearney DL, Edwards WD (1989) Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for the role of sampling error. Mayo Clin Proc 64:1235–1245CrossRefPubMed

21.

Hill KD, Atkinson JB, Doyle TP, Dodd D (2009) Routine performance of endomyocardial biopsy decreases the incidence of orthotopic heart transplant for myocarditis. J Heart Lung Transplant 26:1261–1266CrossRef

22.

Jessup M, Abraham WT, Casey DE et al (2009) 2009 Focused Update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the ACCCF/AHA Task Force on Practice Guidelines: Developed in Collaboration with ISHLT. Circulation 119:1977–2016CrossRefPubMed

23.

Kinderman I, Kinderman M, Kandolf R et al (2008) Predictors of outcome in patients with suspected myocarditis. Circulation 118:639–648CrossRef

24.

Kuhl U, Lauer B, Souvatzoglu M, Vosberg H, Schultheiss HP (1998) Antimyosin scintigraphy and immunohistologic analysis of endomyocardial biopsy in patients with clinically suspected myocarditis evidence of myocardial cell damage and inflammation in the absence of histological signs of myocarditis. J Am Coll Cardiol 32:1371–1376CrossRefPubMed

25.

Lee KJ, McCrindle BW, Bohn DJ et al (1999) Clinical outcomes of acute myocarditis in childhood. Heart 82:226–233PubMedCentralCrossRefPubMed

26.

Lie JT (1988) Myocarditis and endomyocardial biopsy in unexplained heart failure: a diagnosis in search of a disease (editorial). Ann Intern Med 109:525–528CrossRefPubMed

27.

Liu PP, Mason JW (2001) Advances in the understanding of myocarditis. Circulation 104:1076–1082CrossRefPubMed

28.

Martin AB, Webber S, Fricker FJ et al (1994) Acute myocarditis: rapid diagnosis by PCR in children. Circulation 90:330–339CrossRefPubMed

29.

Mason JW, O’Connell JB, Herskowtiz A et al (1995) A clinical trial of immunosuppressive therapy for myocarditis: the myocarditis treatment trial investigators. N Engl J Med 333:269–275CrossRefPubMed

30.

McNamara DM, Holubkov R, Starling RC et al (2001) Controlled trial of intravenous immune globulin in recent-onset cardiomyopathy. Circulation 103:2254–2259CrossRefPubMed

31.

Mendes LA, Dec GW, Picard MH, Palacios IF, Newell J, Davidoff R (1994) Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. Am Heart J 128:301–307CrossRefPubMed

32.

Pietra BA, Kantor PF, Bartlett HL et al (2012) Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy. Circulation 126:1079–1086PubMedCentralCrossRefPubMed

33.

Pophal SG, Sigfusson G, Booth KL et al (1999) Complications of endomyocardial biopsy in children. J Am Coll Cardiol 34:2105–2110CrossRefPubMed

34.

Richardson P, McKenna W, Bristow M et al (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93:841–842CrossRefPubMed

35.

Schmaltz AA, Apitz J, Hort W, Maisch B (1990) Endomyocardial biopsy in infants and children: experience in 60 patients. Pediatr Cardiol 11:15–21CrossRefPubMed

36.

Schultz JC, Hilliard AA, Cooper LT Jr, Rihal CS (2009) Diagnosis and treatment of viral myocarditis. Mayo Clin Proc 84:1001–1009PubMedCentralCrossRefPubMed

37.

Stanton C, Mookadam F, Cha S et al (2008) Greater symptom duration predicts response to immunomodulatory therapy in dilated cardiomyopathy. Int J Cardiol 128:38–41CrossRefPubMed

38.

Wojnicz R, Nowalany-Kozielska E, Wojciechowska C et al (2001) Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104:39–45CrossRefPubMed

Title: Role of Endomyocardial Biopsy for Children Presenting With Acute Systolic Heart Failure
Author: Bibhuti B. Das
Publication date: 01-02-2014
Publisher: Springer US
Published in: Pediatric Cardiology / Issue 2/2014
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-013-0807-0

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Role of Endomyocardial Biopsy for Children Presenting With Acute Systolic Heart Failure

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2014

Fate of Ventricular and Valve Performance Following Early Bidirectional Glenn Procedure After Norwood Operation Controlled for Hypoplastic Left Heart Syndome Anatomic Subtype

Childhood Obesity Increases Left-Ventricular Mass Irrespective of Blood Pressure Status

Electrocardiographic Screening for Hypertrophic Cardiomyopathy and Long QT Syndrome: The Drivers of Cost-Effectiveness for the Prevention of Sudden Cardiac Death

The SCN5A Mutation A1180V is Associated With Electrocardiographic Features of LQT3

Effect of Antiepilepsy Drug Therapy on Ventricular Function in Children With Epilepsy: A Tissue Doppler Imaging Study

How Not to Tell Parents About Their Child’s New Diagnosis of Congenital Heart Disease: An Internet Survey of 841 Parents

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page